Skip to main content

Innovative. Integrated. Industry-Focused.

World-class regulatory, litigation and transactional solutions for your most complex challenges.

  • Regulatory

    Sector-specific expertise to support virtually every aspect of your regulated business activities.

  • Litigation

    Combining creative litigation strategies with business practicality to resolve high-stakes disputes.

  • Transactional

    Trusted advisors for our clients' most complex transactions.

Innovative. Integrated. Industry-Focused.

World-class regulatory, litigation and transactional solutions for your most complex challenges.

  • Regulatory

    Sector-specific expertise to support virtually every aspect of your regulated business activities.

  • Litigation

    Combining creative litigation strategies with business practicality to resolve high-stakes disputes.

  • Transactional

    Trusted advisors for our clients' most complex transactions.

News Commercial Litigation June 22, 2026

Stephanie Kang Rejoins Arnold & Porter Los Angeles Litigation Team Learn More

News June 18, 2026

Pinnacle Women Insights Names Kathleen Harris Among Top 10 Admired Women Leaders Learn More

Blog FCA Qui Notes

The FCA landscape is evolving quickly — and so is Qui Notes. Read our latest blogs for practical insights into the latest enforcement actions, litigation trends, and compliance developments. Stay Current on FCA Developments

News June 11, 2026

Law Times Korea Names Arnold & Porter Best Firm in 2026 Law Firm Consumer Report Learn More

News Antitrust/Competition June 4, 2026

Chambers USA 2026 Ranks 142 Arnold & Porter Lawyers, 75 Practices Learn More

Featured Topic

The GENIUS Act and Stablecoin Regulation Resource Center Understand The Future Of Digital Currency Policy — Learn More

Advisory Life Sciences & Healthcare Regulatory June 24, 2026

FDA Issues Revised Draft Guidance on Demonstrating Substantial Evidence of Effectiveness for Human Drugs and Biological Products Learn More

Advisory Global Life Sciences June 24, 2026

FDA Proposes Expedited Investigational New Drug Pilot Program to Drive Early Phase Clinical Research in the United States Learn More

Featured Topic

Middle East Crisis: Navigating the Conflict with Iran Learn More About Our Strategic Advisory and Counsel Services

Further Reading

Arnold & Porter by the Numbers

107K+

2025 Total Pro Bono Hours

16

Offices Worldwide

173

Chambers-Ranked Lawyers